Holen Sie sich die Stockscreener-App
120.69
0.67%
0.80
Vorhandelsmarkt:
121.00
0.31
+0.26%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$119.89
Offen:
$120
24-Stunden-Volumen:
723.04K
Relative Volume:
0.78
Marktkapitalisierung:
$5.34B
Einnahmen:
$2.96B
Nettoeinkommen (Verlust:
$-194.74M
KGV:
-5.871
EPS:
-20.557
Netto-Cashflow:
$245.44M
1W Leistung:
-10.94%
1M Leistung:
+2.44%
6M Leistung:
-3.25%
1J Leistung:
-1.80%
1-Tages-Spanne:
$118.52
$121.21
1-Wochen-Bereich:
$118.52
$136.44
52-Wochen-Spanne:
$100.18
$139.67
Teleflex Incorporated Stock (TFX) Company Profile
Firmenname
Teleflex Incorporated
Sektor
Telefon
610-225-6800
Adresse
550 E SWEDESFORD RD, WAYNE, PA
Compare TFX vs ISRG, BDX, MDLN, ALC, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TFX
Teleflex Incorporated
|
120.69 | 5.34B | 2.96B | -194.74M | 245.44M | -20.56 |
ISRG
Intuitive Surgical Inc
|
451.38 | 159.86B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
144.17 | 41.01B | 21.92B | 1.76B | 2.63B | 6.1223 |
MDLN
Medline Inc
|
45.32 | 38.32B | 28.43B | 1.16B | 1.26B | 1.4457 |
ALC
Alcon Inc
|
74.45 | 36.29B | 10.40B | 980.00M | 1.61B | 1.9749 |
RMD
Resmed Inc
|
207.88 | 30.15B | 5.40B | 1.49B | 1.78B | 10.12 |
Teleflex Incorporated Stock (TFX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-13 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2026-03-27 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2026-01-27 | Hochstufung | Needham | Hold → Buy |
| 2025-03-04 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2025-02-28 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-02-28 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-02-28 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2025-02-27 | Herabstufung | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2024-07-01 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-12-04 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-06-21 | Herabstufung | Needham | Buy → Hold |
| 2023-05-30 | Eingeleitet | CL King | Buy |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-04-26 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2022-10-26 | Eingeleitet | Mizuho | Neutral |
| 2022-10-14 | Fortgesetzt | Stephens | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-07-29 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-07-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-05-09 | Eingeleitet | BofA Securities | Neutral |
| 2022-04-13 | Eingeleitet | Truist | Hold |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-10-07 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-09-07 | Fortgesetzt | Raymond James | Outperform |
| 2021-07-19 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2021-01-06 | Bestätigt | Needham | Buy |
| 2020-11-02 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-01-31 | Bestätigt | Needham | Buy |
| 2019-08-02 | Bestätigt | Needham | Buy |
| 2019-06-11 | Eingeleitet | Wells Fargo | Outperform |
| 2019-04-24 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-02-22 | Bestätigt | Needham | Strong Buy |
| 2018-10-16 | Eingeleitet | Barclays | Equal Weight |
| 2018-09-10 | Hochstufung | Needham | Buy → Strong Buy |
| 2018-08-03 | Bestätigt | Needham | Buy |
| 2018-05-14 | Bestätigt | Needham | Buy |
| 2018-05-04 | Bestätigt | Needham | Buy |
| 2018-04-04 | Eingeleitet | Goldman | Neutral |
| 2017-11-10 | Fortgesetzt | Piper Jaffray | Overweight |
| 2017-11-03 | Bestätigt | Needham | Buy |
| 2017-09-08 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2017-09-06 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2017-09-06 | Bestätigt | Needham | Buy |
| 2017-03-07 | Eingeleitet | Needham | Buy |
| 2017-01-06 | Hochstufung | Jefferies | Hold → Buy |
| 2016-07-12 | Herabstufung | KeyBanc Capital Mkts | Overweight → Sector Weight |
Alle ansehen
Teleflex Incorporated Aktie (TFX) Neueste Nachrichten
Strs Ohio Acquires 11,002 Shares of Teleflex Incorporated $TFX - MarketBeat
Teleflex Features ARROW® JACC with Chlorag+ard® Technology, the Only Long-Term Antimicrobial and Ant - Yahoo
Teleflex Incorporated $TFX Shares Sold by Vanguard Group Inc. - MarketBeat
PFA Pension Forsikringsaktieselskab Buys New Position in Teleflex Incorporated $TFX - MarketBeat
Teleflex Inc. stock underperforms Monday when compared to competitors - MarketWatch
Teleflex Schedules First-Quarter Earnings Call for May 7 - MyChesCo
Teleflex gains on report PE firms teamed up for takeover offer (update) - MSN
Medical device maker Teleflex appoints new CEO - MSN
Teleflex™ Chooses o9's AI-Powered Platform for End-to-End Integrated Business Planning and Supply Chain Management - Quantisnow
Earnings Preview: Teleflex to Report Financial Results Pre-market on May 07 - Moomoo
Teleflex Names Jason Weidman as New CEO - The Globe and Mail
Teleflex Inc. stock underperforms Friday when compared to competitors - MarketWatch
TFX Stock Price, Quote & Chart | TELEFLEX INC (NYSE:TFX) - ChartMill
Teleflex hires Jason Weidman as CEO - MedTech Dive
Teleflex Inc. stock underperforms Thursday when compared to competitors - MarketWatch
New Teleflex (NYSE: TFX) CEO to lead amid $1B buyback and debt plan - Stock Titan
Teleflex Names Jason Weidman CEO As Valuation Gap And Risks Draw Focus - Yahoo Finance
Vanguard (TFX) discloses 2.32M-share stake, 5.25% ownership reported - Stock Titan
Teleflex (NYSE:TFX) Trading Down 7%What's Next? - MarketBeat
Teleflex (TFX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release - Yahoo Finance
Teleflex Names Medtronic Exec Jason Weidman as CEO - Medical Product Outsourcing
Teleflex Names Jason Weidman President and CEO - citybiz
Teleflex says Irenic falsely claimed company was not open for buyout offers - MSN
Teleflex Inc. Stock (US8793691069): Vanguard Reports 5.56% Stake in 13G Filing - AD HOC NEWS
Zacks Research Upgrades Teleflex (NYSE:TFX) to "Hold" - MarketBeat
Teleflex names Jason Weidman as CEO effective June 8 By Investing.com - Investing.com South Africa
Teleflex names Jason Weidman as CEO effective June 8 - Investing.com UK
Teleflex Incorporated Announces President Changes - marketscreener.com
Teleflex Incorporated $TFX Shares Acquired by Universal Beteiligungs und Servicegesellschaft mbH - MarketBeat
Teleflex Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Vanguard 13G: Teleflex (NYSE: TFX) reports 2.46M shares, 5.56% - Stock Titan
Teleflex Settles Catheter Patent Case Against Medtronic - Law360
Teleflex Inc. stock (US8793691069): Is its medical device moat strong enough to unlock new upside? - AD HOC NEWS
Teleflex stock surges over 8% in pre-market trading: Here's why - MSN
Teleflex Incorporated (TFX) Stock Analysis: Navigating the Healthcare Sector with Caution Amid Mixed Ratings - DirectorsTalk Interviews
M&T Bank Corp Raises Holdings in Teleflex Incorporated $TFX - MarketBeat
Teleflex (NYSE:TFX) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Teleflex gains on report PE firms teamed up for takeover offer - MSN
Teleflex Stock Surges Over 8% In Pre-Market Trading: Here's Why - Sahm
PE giants eye Teleflex in potential takeover bid - BioXconomy
Eos Management L.P. Makes New $3.76 Million Investment in Teleflex Incorporated $TFX - MarketBeat
Teleflex Announces First Quarter 2026 Earnings Conference Call Information - Business Wire
Teleflex stock hits 52-week high at 138.95 USD By Investing.com - Investing.com India
Teleflex (TFX) to Release Earnings on Thursday - MarketBeat
Teleflex (NYSE:TFX) Reaches New 12-Month HighHere's Why - MarketBeat
TFX (Teleflex Incorporated) records 17.2 percent year over year revenue growth despite Q4 2025 EPS miss, shares edge higher.CFO Commentary - Xã Thanh Hà
Finanzdaten der Teleflex Incorporated-Aktie (TFX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.78%
0.44%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):